Dear Doctor - Participate in the Survey on psoriatic arthritis " A new survey has found that psoriatic arthritis can have a significant impact on patients' quality of life. The study, which was conducted by the National Psoriasis Foundation (NPF), surveyed more than 3,500 people with psoriatic arthritis and found that the condition can severely affect patients physically, emotionally, and socially.The NPF survey found that psoriatic arthritis can cause pain, fatigue, stiffness, joint damage, and disability. The condition can also lead to depression and anxiety. In addition, the survey found that people with psoriatic arthritis are often socially isolated and have difficulty keeping up with work and daily activities."This survey provides new insights into the real-world impact of psoriatic arthritis," said NPF President Andrew Prince. "It's important for people with psoriatic arthritis to know they are not alone. There are a wide variety of resources available to help manage this complex disease." Participate in Surveys "
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation